Correlation between lamivudine plasma concentrations and patient self-reported adherence to antiretroviral treatment in experienced HIV patients

Item

http://www.wikidata.org/entity/Q35600417

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Correlation between lamivudine ...... nt in experienced HIV patients

@ast

Correlation between lamivudine ...... nt in experienced HIV patients

@en

type

Item

label

Correlation between lamivudine ...... nt in experienced HIV patients

@ast

Correlation between lamivudine ...... nt in experienced HIV patients

@en

prefLabel

Correlation between lamivudine ...... nt in experienced HIV patients

@ast

Correlation between lamivudine ...... nt in experienced HIV patients

@en

P1476

Correlation between lamivudine ...... nt in experienced HIV patients

@en

P2093

Ll Gustafsson

http://www.w3.org/2001/XMLSchema#string

Om Minzi

http://www.w3.org/2001/XMLSchema#string

V Mugoyela

http://www.w3.org/2001/XMLSchema#string

P2860

Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.

Factors affecting adherence to antiretroviral therapy.

Population pharmacokinetics of lamivudine in adult human immunodeficiency virus-infected patients enrolled in two phase III clinical trials.

Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.

The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials.

Simplified Assessment of Antiretroviral Adherence and Prediction of Virological Efficacy in HIV-Infected Patients in Cambodia

Macrocytosis as an indicator of medication (zidovudine) adherence in patients with HIV infection.

Equivalent steady-state pharmacokinetics of lamivudine in plasma and lamivudine triphosphate within cells following administration of lamivudine at 300 milligrams once daily and 150 milligrams twice daily.

Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction.

Adherence to antiretroviral therapy: are we doing enough?

P304

441-446

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/TCRM.S23625

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22162920

http://www.w3.org/2001/XMLSchema#string

P932

3233527

http://www.w3.org/2001/XMLSchema#string